Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer

Genes and Immunity

Volumn 15, Issue 4, 2014, Pages 199-209

  Trejo De La O, A ^a   Hernandez Sancen P ^b   Maldonado Bernal, C ^a  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b Departamento de Asesoría Molecular Roche Diagnostics México   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INFECTION; INFLAMMATORY DISEASE; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFLAMMATION; NEOPLASM;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFECTION; INFLAMMATION; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTORS;

EID: 84902115681     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.10     Document Type: Review

References (114)

1. Albiger B, Dahlberg S, Henriques-Normark B, Normark S. Role of the innate immune system in host defence against bacterial infections: Focus on the Tolllike receptors. J Intern Med 2007; 261: 511-528. (Pubitemid 46835986
2. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998; 95: 588-593. (Pubitemid 28083787
3. Du X, Poltorak A, Wei Y, Beutler B. Three novel mammalian toll-like receptors: Gene structure, expression, and evolution. Eur Cytokine Netw 2000; 11: 362-371. (Pubitemid 32268893
4. Chuang T, Ulevitch RJ. Identification of hTLR10: A novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001; 1518: 157-161. (Pubitemid 32232289
5. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA et al. A tolllike receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 1522-1526. (Pubitemid 38314423
6. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274: 33419-33425. (Pubitemid 129511647
7. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kB by Toll-like receptor 3. Nature 2001; 413: 732-738. (Pubitemid 33009951
8. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S et al. Speciesspecific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-1529. (Pubitemid 38314424
9. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-10692
10. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099-1103. (Pubitemid 32391041
11. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745. (Pubitemid 32015992
12. Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007; 4: 444-454. (Pubitemid 47180328
13. Kim JK. Fat uses a TOLL - road to connect inflammation and diabetes. Cell Metab 2006; 4: 417-419. (Pubitemid 44817355
14. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007; 7: 1271-1285. (Pubitemid 47126372
15. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241. (Pubitemid 38962578
16. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752. (Pubitemid 29314747
17. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282: 2085-2088. (Pubitemid 29001265
18. Takeda K, Takeuchi O, Akira S. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 2002; 8: 459-463. (Pubitemid 36104601
19. Sun J, Wiklund F, Hsu FC, Bailter K, Zheng SL, Johansson JE et al. Interactions of sequence variants in interleukin-1 receptor-Associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 480-485
20. Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, Quy HT et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 2007; 37: 2280-2289. (Pubitemid 47250219
21. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E et al. Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 2007; 178: 7520-7524. (Pubitemid 46898019
22. Yang CA, Scheibenbogen C, Bauer S, Kleinle C, Wex T, Bornschein J et al. A frequent Toll-like receptor 1 gene polymorphism affects NK- And T-cell INF-g production and is associated with Helicobacter pylori-induced gastric disease. Helicobacter 2013; 18: 13-21
23. Omueti KO, Mazur DJ, Thompson KS, Lyle EA, Tapping RI. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J Immunol 2007; 178: 6387-6394. (Pubitemid 46729197
24. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68: 6398-6401
25. Schröder NW, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 2005; 175: 2534-2540. (Pubitemid 41113865
26. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23: 219-223. (Pubitemid 38195506
27. Tabel Y, Berdeli A, Mir S. Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children. Int J Immunogenet 2007; 34: 399-405. (Pubitemid 350126007
28. Kutukculer N, Yeniay BS, Aksu G, Berdeli A. Arg753Gln polymorphism of the human toll-like receptor-2 gene in children with recurrent febrile infections. Biochem Genet 2007; 45: 507-514. (Pubitemid 47222802
29. Berdeli A, Celik HA, Ozyürek R, Dogrusoz B, Aydin HH. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med 2005; 83: 535-541. (Pubitemid 41126069
30. Ozen S, Berdeli A, Turel B, Kutlay S, Yalcinkaya F, Arici M et al. Arg753Gln TLR-2 polymorphism in familial mediterranean fever: Linking the environment to the phenotype in a monogenic inflammatory disease. J Rheumatol 2006; 33: 2498-2500. (Pubitemid 46067831
31. Hamann L, Gomma A, Schröder NW, Stamme C, Glaeser C, Schulz S et al. A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J Mol Med 2005; 83: 478-485. (Pubitemid 40922170
32. Park Y, Park S, Yoo E, Kim D, Shin H. Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility. Ann NY Acad Sci 2004; 1037: 170-174. (Pubitemid 40299762
33. Eid AJ, Brown RA, Paya CV, Razonable RR. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 2007; 84: 511-516. (Pubitemid 47312163
34. Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 2007; 44: 1315-1320. (Pubitemid 46717293
35. Krediet TG, Wiertsema SP, Vossers MJ, Hoeks SB, Fleer A, Ruven HJ et al. Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr Res 2007; 62: 474-476. (Pubitemid 47476208
36. Kang TJ, Chae GT. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001; 31: 53-58
37. Kang TJ, Lee SB, Chae GT. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 2002; 20: 56-62. (Pubitemid 35373721
38. Kang TJ, Yeum CE, Kim BC, You EY, Chae GT. Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology 2004; 112: 674-680
39. Ben Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004; 11: 625-626. (Pubitemid 38661434
40. Schröder NW, Hermann C, Hamann L, Göbel UB, Hartung T, Schumann RR. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 2003; 81: 368-372. (Pubitemid 36783241
41. Hise AG, Hazlett FE, Bockarie MJ, Zimmerman PA, Tisch DJ, Kazura JW. Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis. Genes Immun 2003; 4: 524-527. (Pubitemid 38967621
42. Berdeli A, Emingil G, Han Saygan B, Gurkan A, Atilla G, Köse T et al. TLR2 Arg753Gly, TLR4 Asp299Gly and Thr399Ile gene polymorphisms are not associated with chronic periodontitis in a Turkish population. J Clin Periodontol 2007; 34: 551-557
43. Düzgün N, Duman T, Haydardedeoǧlu FE, Tutkak H. The lack of genetic association of the Toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease. Clin Rheumatol 2007; 26: 915-919
44. Yoon HJ, Choi JY, Kim CO, Park YS, Kim MS, Kim YK et al. Lack of Toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia. J Korean Med Sci 2006; 21: 979-982
45. Sánchez E, Orozco G, Ló pez-Nevot MA, Jiménez-Alonso J, Martin J. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63: 54-57
46. von Aulock S, Schröder NW, Traub S, Gueinzius K, Lorenz E, Hartung T et al. Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses. Infect Immun 2004; 72: 1828-1831. (Pubitemid 38263813
47. Merx S, Neumaier M, Wagner H, Kirschning CJ, Ahmad-Nejad P. Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene. Hum Mol Genet 2007; 10: 1225-1232. (Pubitemid 47062718
48. Thuong NT, Hawn TR, Thwaites GE, Chau TT, Lan NT, Quy HT et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun 2007; 8: 422-428. (Pubitemid 47163105
49. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrlainder C et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004; 113: 482-488. (Pubitemid 38338954
50. Junjie X, Songyao J, Minmin S, Yanyan S, Baiyong S, Xiaxing D et al. The association between Toll-like receptor 2 single-nucleotide polymorphism and hepatocellular carcinoma susceptibility. BMC Cancer 2012; 12: 57
51. Theodoropoulos GE, Saridakis V, Karantanos T, Michalopoulos NV, Zagouri F, Kontogianni P et al. Toll-like receptor gene polymorphisms may confer increased susceptibility to breast cancer development. Breast 2012; 21: 534-538
52. Zeng HM, Pan KF, Zhang Y, Zhang L, Ma JL, Zhou T et al. Genetic variants of Tolllike receptors 2 and 5, Helicobacter pylori infection, and risk of gastric cancer and its precursors in a Chinese population. Cancer Epidemiol Biomarkers Prev 2011; 20: 2594-2602
53. Ranjith-Kumar CT, Miller W, Sun J, Xiong J, Santos J, Yarbrough I et al. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem 2007; 282: 17696-17705. (Pubitemid 47100325
54. Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol 2007; 91: 962-965. (Pubitemid 47013114
55. Pirie FJ, Pegoraro R, Motala AA, Rauff S, Rom L, Govender T et al. Toll-like receptor 3 gene polymorphisms in South African blacks with type 1 diabetes. Tissue Antigens 2005; 66: 125-130. (Pubitemid 41025934
56. Castro FA, Försti A, Buch S, Kalthoff H, Krauss C, Bauer M et al. TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur J Cancer 2011; 47: 1203-1210
57. Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P et al. Evaluation of Toll-like receptor 3 (c.1377C/T) and 9 (G2848A) gene polymorphism in cervical cancer susceptibility. Mol Biol Rep 2011; 38: 4715-4721
58. Smirnova I, Poltorak A, Chan EK, McBride C, Beutler B. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol 2000; 1: Research002.1-research002.10
59. Smirnova I, Hamblin MT, McBride C, Beutler B, Di Rienzo A. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 2001; 158: 1657-1664. (Pubitemid 32783146
60. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-191. (Pubitemid 30394990
61. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E et al. Toll-like receptor 4 polymorphisms and atherogenesis. New Engl J Med 2002; 18: 185-192. (Pubitemid 34764822
62. Fageras Böttcher M, Hmani-Aifa M, Lindström A, Jenmalm MC, Mai XM, Nilsson L et al. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 2004; 114: 561-567
63. Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW. TLR4 and TNF-A polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004; 41: 808-813. (Pubitemid 39524306
64. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002; 162: 1028-1032. (Pubitemid 34492532
65. Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 2002; 52: 373-376. (Pubitemid 34920267
66. Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, Shelling AN et al. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene?. Association study combined with meta-Analysis shows strong evidence for association. Am J Gastroenterol 2007; 102: 2504-2512. (Pubitemid 47631777
67. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T et al. Deficient host-bacteria interactions in inflammatory bowel disease?. The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004; 53: 987-992. (Pubitemid 38824157
68. Lakatos PL, Lakatos L, Szalay F, Willheim-Polli C, Osterreicher C, Tulassay Z et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: Phenotype-genotype correlations. World J Gastroenterol 2005; 11: 1489-1495. (Pubitemid 40468084
69. Montes AH, Asensi V, Alvarez V, Valle E, Ocan a MG, Meana A et al. The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gramnegative and haematogenous osteomyelitis. Clin Exp Immunol 2006; 143: 404-413
70. Karoly E, Fekete A, Banki NF, Szebeni B, Vannay A, Szabo AJ et al. Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children. Pediatr Res 2007; 61: 371-374
71. Tulic MK, Hurrelbrink RJ, Prê le CM, Laing IA, Upham JW, Le Souef P et al. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 2007; 179: 132-140. (Pubitemid 46986527
72. Hellmig S, Fischbach W, Goebeler-Kolve ME, Fölsch UR, Hampe J, Schreiber S. Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-Associated lymphoid tissue lymphoma. Leuk Lymphoma 2005; 46: 869-872
73. Hofner P, Gyulai Z, Kiss ZF, Tiszai A, Tiszlavicz L, Tó th G et al. Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 2007; 12: 124-131
74. Kato I, Canzian F, Plummer M, Franceschi S, van Doorn LJ, Vivas J et al. Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci 2007; 52: 254-261. (Pubitemid 46122076
75. Trejo-de la OA, Torres J, Pé rez-Rodríguez M, Camorlinga-Ponce M, Luna LF, Abdo-Francis JM et al. TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pyloriassociated gastroduodenal diseases. Clin Immunol 2008; 129: 333-340
76. Pabst S, Baumgarten G, Stremmel A, Lennarz M, Knüfermann P, Gillissen A et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 2006; 143: 420-426
77. Rudofsky Jr G, Reismann P, Witte S, Humpert PM, Isermann B, Chavakis T et al. Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes. Diabetes Care 2004; 27: 179-183. (Pubitemid 38196729
78. Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF et al. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 2006; 20: 30-36. (Pubitemid 43349021
79. Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen E et al. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett 2006; 391: 147-149. (Pubitemid 41736189
80. Van Der Graaf CA, Netea MG, Morré SA, Den Heijer M, Verweij PE, Van Der Meer JW et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 2006; 17: 29-34
81. Hofner P, Balog A, Gyulai Z, Farkas G, Rakonczay Z, Takács T et al. Polymorphism in the IL-8 gene, but not in the TLR4 gene, increases the severity of acute pancreatitis. Pancreatology 2006; 6: 542-548. (Pubitemid 46360712
82. Szebeni B, Szekeres R, Rusai K, Vannay A, Veres G, Treszl A et al. Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants. J Pediatr Gastroenterol Nutr 2006; 42: 27-31. (Pubitemid 43061006
83. Na KS, Kim TH, Rahman P, Peddle L, Choi CB, Inman RD. Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population. Rheumatol Int 2008; 28: 627-630
84. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 2005; 65: 11771-11778. (Pubitemid 41821739
85. Duan ZX, Zhu PF, Dong H, Gu W, Yang C, Liu Q et al. Functional significance of the TLR4/11367 polymorphism identified in Chinese Han population. Shock 2007; 28: 160-164. (Pubitemid 47220826
86. Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L. Molecular interactions between Dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res 2008; 68: 4026-4030
87. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ et al. A common Dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 2003; 198: 1563-1572. (Pubitemid 37467170
88. Dunstan SJ, Hawn TR, Hue NT, Parry CP, Ho VA, Vinh H et al. Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J Infect Dis 2005; 191: 1068-1071. (Pubitemid 40404365
89. Demirci FY, Manzi S, Ramsey-Goldman R, Kenney M, Shaw PS, Dunlop-Thomas CM et al. Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J Rheumatol 2007; 34: 1708-1711. (Pubitemid 47267614
90. Hawn TR, Wu H, Grossman JM, Hahn BH, Tsao BP, Aderem A. A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci USA 2005; 102: 10593-10597. (Pubitemid 41061599
91. Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH. Dominantnegative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1157-G1163. (Pubitemid 43788297
92. Sun J, Wiklund F, Zheng SL, Chang B, Bailter K, Li L et al. Sequence variants in Tolllike receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst 2005; 97: 525-532. (Pubitemid 40590434
93. Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006; 12: 1-8
94. Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007; 110: 4455-4463. (Pubitemid 351377812
95. Cheng PL, Eng HL, Chou MH, You HL, Lin TM. Genetic polymorphisms of viral infection-Associated Toll-like receptors in Chinese population. Transl Res 2007; 150: 311-318
96. Schott E, Witt H, Neumann K, Taube S, Oh DY, Schreier E et al. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. J Hepatol 2007; 47: 203-211. (Pubitemid 47021254
97. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): Frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 2003; 81: 85-91. (Pubitemid 36263362
98. Török HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C. Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 2004; 127: 365-366
99. Lammers KM, Ouburg S, Morré SA, Crusius JB, Gionchett P, Rizzello F et al. Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. World J Gastroenterol 2005; 11: 7323-7329. (Pubitemid 43137684
100. Ng MW, Lau CS, Chan TM, Wong WH, Lau YL. Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese. Rheumatology (Oxford) 2005; 44: 1456-1457. (Pubitemid 41631873
101. De Jager PL, Richardson A, Vyse TJ, Rioux JD. Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus erythematosus. Arthritis Rheum 2006; 54: 1279-1282. (Pubitemid 43672940
102. Berghöfer B, Frommer T, König IR, Ziegler A, Chakraborty T, Bein G et al. Common human Toll-like receptor 9 polymorphisms and haplotypes: Association with atopy and functional relevance. Clin Exp Allergy 2005; 35: 1147-1154
103. Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M et al. An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 2004; 34: 177-183. (Pubitemid 38315251
104. Kikuchi K, Lian ZX, Kimura Y, Selmi C, Yang GX, Gordon SC et al. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 2005; 24: 347-352. (Pubitemid 40775859
105. Mockenhaupt FP, Hamann L, von Gaertner C, Bedu-Addo G, von Kleinsorgen C, Schumann RR et al. Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J Infect Dis 2006; 194: 184-188. (Pubitemid 44087189
106. Bochud PY, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD et al. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 2007; 21: 441-446
107. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J et al. Toll-like receptor (TLR) and nucleosome-binding oligomerization Domain (NOD) gene polymorphisms and endometrial cancer risk. BMC Cancer 2010; 10: 382
108. Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 2005; 174: 2942-2950. (Pubitemid 40279713
109. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511. (Pubitemid 38931765
110. Lazarus R, Raby BA, Lange C, Silverman EK, Kwiatkowski DJ, Vercelli D et al. Tolllike receptor 10 genetic variation is associated with asthma in two independent samples. Am J Respir Crit Care Med 2004; 170: 594-600. (Pubitemid 39202199
111. Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J et al. Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol 2008; 122: 86-92
112. Abad C, González-Escribano MF, Diaz-Gallo LM, Lucena-Soto JM, Márquez JL, Leo E et al. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2. Genes Immun 2011; 12: 635-642
113. Morgan AR, Lam WJ, Han DY, Fraser AG, Ferguson LR. Genetic variation within TLR10 is associated with Crohn's disease in a New Zealand population. Hum Immunol 2012; 73: 416-420
114. Kim SK, Park HJ, Hong IK, Chung JH, Eun YG. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population. Endocrine 2013; 43: 161-169.